Comparative efficacy and safety of extended-release and instant-release tolterodine in children with neural tube defects having cystometric abnormalities

Journal of Pediatric Urology

Volumn 4, Issue 2, 2008, Pages 118-123

  Mahanta, Kinkar ^a   Medhi, Bikas ^a   Kaur, Balpinder ^a   Narasimhan, Kannan Laksmi ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Neural tube defects; Short acting tolterodine; Tolterodine extended release

Indexed keywords

SUCCIMER TC 99M; TOLTERODINE;

ADOLESCENT; ARTICLE; BLADDER CAPACITY; BLADDER COMPLIANCE; BLADDER PRESSURE; BLOOD ANALYSIS; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; CYSTOMETRY; DEMOGRAPHY; DIARRHEA; DRUG EFFICACY; DRUG FORMULATION; DRUG SAFETY; DRUG TOLERABILITY; ECHOGRAPHY; FLUOROSCOPY; FLUSHING; HUMAN; HYDROURETER; HYPERPYREXIA; KIDNEY DYSFUNCTION; KIDNEY FUNCTION TEST; KIDNEY SCAR; KIDNEY SCINTISCANNING; LIVER FUNCTION TEST; LUMBOSACRAL SPINE; MICTURITION CYSTOURETHROGRAPHY; NEURAL TUBE DEFECT; NEUROGENIC BLADDER; PRIORITY JOURNAL; SIDE EFFECT; SPINE RADIOGRAPHY; URINE CULTURE; URODYNAMICS; VESICOURETERAL REFLUX; VISUAL ANALOG SCALE; XEROSTOMIA;

ADOLESCENT; BENZHYDRYL COMPOUNDS; CHILD; CHILD, PRESCHOOL; CRESOLS; DELAYED-ACTION PREPARATIONS; HUMANS; MUSCARINIC ANTAGONISTS; NEURAL TUBE DEFECTS; PHENYLPROPANOLAMINE; PRESSURE; TREATMENT OUTCOME; URINARY BLADDER; URINARY BLADDER, NEUROGENIC;

EID: 40849137922     PISSN: 14775131     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpurol.2007.10.011     Document Type: Article

References (26)

1. Fackelman K.A. Closing in on neural tube defects. Sci News 44 (1993) 30
2. Seller M.J. Recent developments in the understanding of the aetiology of neural tube defects. Clin Dysmorphol 4 (1995) 93-104
3. Joseph D., Bauer S.B., Colodny A.H., Mandell J., and Retik AB. Clean, intermittent catheterization of infants with neurogenic bladder. Pediatrics 84 (1989) 78-82
4. Cartwright P.C., and Snow B.W. Bladder and urethra. In: Ashcraft K.W., Holcomb G.W., and Murphy J.P. (Eds). Pediatric surgery. 4th ed. (2005), W.B. Saunders 776-780
5. Thorup J. Urodynamic examination of the lower urinary tract in children with normal & congenital neurogenic bladder. Scand J Urol Nephrol 158 Suppl (1994) 1
6. Andersson K.E. Current concepts in the treatment of disorders of micturition. Drugs 35 (1988) 477-494
7. Hjalmas K., Hellstrom A.L., Mogren K., Lackgren G., and Stenberg A. The overactive bladder in children: a potential future indication for tolterodine. Br J Urol Int 87 (2001) 569-574
8. Ellsworth P.I., Borgstein N.G., Nijman R.J., and Reddy P.P. Use of tolterodine in children with neurogenic detrusor overactivity: relationship between dose and urodynamic response. J. Urol 174 (2005) 1647-1651
9. International Reflux Study Committee. Medical versus surgical treatment of primary vesicoureteral reflux: a prospective international reflux study in children. J Urol 125 (1981) 277-283
10. Neveus T., von Gontard A., Hoebeke P., Hjalmas K., Bauer S., Bower W., et al. The standardization of terminology of lower urinary tract function in children and adolescents: report from the Standardization Committee of the International Children's Continence Society. J Urol 176 (2006) 314-324
11. Khoury A.E., Houle A.M., McLorie G.A., and Churchill B.M. Cutaneous vesicostomy effect on bladder's eventual function. Dial Pediatr Urol 13 (1990) 4-7
12. Kim Y.H., Horowitz M., Combs A., Nitti V.W., Libretti D., and Glassberg K.I. Comparative urodynamic findings after primary valve ablation, vesicostomy or proximal diversion. J Urol 156 (1996) 673-676
13. Brynee N., Stahl M.M., Hallen B., Edlund PO., Palmer L., Hoglund P., et al. Pharmacokinetics and pharmodynamics of tolterodine in man: a new drug for the treatment of urinary bladder over activity. Int J Clin Pharmacol Ther 35 (1997) 287-295
14. Abrams P., Freeman R., Anderstrom C., and Mattiasson A. Tolterodine, a new antimuscarinic agent: as effective but better tolerated than oxybutynin in patients with an overactive bladder. Br J Urol 81 (1998) 801-810
15. Larsson G., Hallen B., and Nilvebrant L. Tolterodine in the treatment of overactive bladder: analysis of the pooled phase II efficacy and safety data. Urology 50 (1999) 990-998
16. Kilic N., Balkan E., Akgoz S., Sen N., and Dogruyol H. Comparison of the effectiveness and side effects of tolterodine and oxybutynin in children with detrusor instability. Int J Urol 13 (2006) 105-108
17. Yucel S., Akkaya E., Guntekin E., Kukul E., Danisman A., Akman S., et al. Should we switch over to tolterodine in every child with non-neurogenic daytime urinary incontinence in whom oxybutynin failed?. Urology 65 (2005) 369-373
18. Bolduc S., Upadhyay J., Payton J., Bagli D.J., McLorie G.A., Khoury A.E., et al. The use of tolterodine in children after oxybutynin failure. Br J Urol Int 91 (2003) 398-401
19. Munding M., Wessells H., Thronberry B., and Riden D. Use of tolterodine in children with dysfunctional voiding; an initial report. J Urol 165 (2001) 926-928
20. Goessl C., Knispel H.H., Fiedler U., Harle B., Steffen-Wilke K., and Miller K. Urodynamic effects of oral Oxybutynin chloride in children with myelomeningocele and detrusor hyperreflexia. Urology 51 (1998) 94-98
21. Ayan S., Kaya K., Topsakal K., Kilicarslan H., Gokce G., and Gultein Y. Efficacy of tolterodine as a first -line treatment for non-neurogenic voiding dysfunction in children. Br J Urol Int 96 (2005) 411-414
22. McGuire E.J., Woodside J.R., Borden T.A., and Weiss R.M. Prognostic value of urodynamic testing in myelodyspolasia patients. J Urol 1126 (1981) 205-209
23. Wagg A., and Malone-Lee J. Pressure-flow variables in patients treated with tolterodine for detrusor overactivity. Br J Urol Int 92 (2003) 969-971
24. Light J.K., and Pietro T. Alteration in detrusor behavior and the effect on renal function following insertion of the artificial urinary sphincter. J Urol 36 (1986) 632-635
25. Schlegel J. Scintillation camera in diagnosis of renal and urinary tract disease. Urology 2 (1973) 361-364
26. Bosch R., and Groen J. Urethral resistance is related to type of incontinence: changing etiologic concepts in female incontinence. Neurourol Urodyn 17 (1998) 386